Dr. John Andrew Payne, DO

Dr. Payne practices at University Medical Center in Lubbock, Texas, part of Lubbock County, TX.

Dr. Payne's NPI, 1477991180, was assigned on June 5, 2013. Dr. Payne graduated from Kirksville College of Osteopathic Medicine in 2013. Dr. Payne holds Texas license Q6260.

Dr. Payne's primary practice is University Medical Center, at 602 Indiana Avenue, Lubbock, TX 79415 in Lubbock County. The practice phone is (806) 775-8200.

Dr. Payne's primary practice is University Medical Center in Lubbock, Texas, part of Lubbock County, TX. The medical group on file is Texas Tech Physicians. Dmand AI also links Dr. Payne to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Payne practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Payne's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Payne is board certified in internal medicine by the American Board of Internal Medicine. Dr. Payne is licensed in Texas.

Dmand AI lists acute respiratory failure, arthritis, asthma, atrial fibrillation and flutter, chronic diabetes, chronic hypertension, chronic kidney disease and chronic obstructive pulmonary disease (COPD) among the conditions Dr. Payne treats.

CMS data shows 626 Medicare services from Dr. Payne across 9 procedure codes in 2024, for 178 Medicare patients. Medicare paid $51,212 for them.

CMS counts 178 Medicare patients who saw Dr. Payne in 2024. The largest group is 65 to 74, with 63 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Payne's median patient age at 69, with 55% women.

In 2024, Dr. Payne wrote 1,136 Medicare Part D claims for 117 patients. 75% of them were for generic drugs. CMS names the drug for 723 of them, across 25 drugs with 11 or more claims each, at $153,726 in total drug cost. In 2023, CMS named 748 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Payne for performance year 2024, reported through an alternative payment model (APM). Dr. Payne accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 12 papers to Dr. Payne, published from 2019 to 2021. 2019 was the busiest year, with 4. The most frequent topics are Breast Neoplasms. Dr. Payne has published most often in Proc (Bayl Univ Med Cent). Dr. Payne's most frequent co-authors are Joshua Payne, MD, Kenneth Michael Nugent, MD and Ruth Elizabeth Berggren, MD.

CMS Open Payments shows 23 general payments to Dr. Payne from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 91% of the total. Novo Nordisk Inc paid the most, $2,808.

Dmand AI lists 10 awards for Dr. Payne, most recently Unsung Hero in 2020.

Dr. Payne graduated from Kirksville College of Osteopathic Medicine in 2013. Dr. Payne is a member of AOA and ACP.

Dr. Payne is in network with 20 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.